Chanchlani N, Lin S, Chee D, Hamilton B, et al. Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients. J Crohns Colitis 2022;16:389-397.
PMID: 34473254